Ginkgo Bioworks Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $213.4M | $207.4M |
| FY2019 | — | $501.9M | $495.3M |
| FY2020 | — | $461.4M | $380.8M |
| FY2021 | — | $1.51B | $1.55B |
| FY2022 | — | $1.74B | $1.32B |
| FY2023 | — | $1.10B | $944.1M |
| FY2024 | — | $716.1M | $561.6M |
| FY2025 | — | $508.6M | $167.2M |